1. Home
  2. MCHX vs RVPH Comparison

MCHX vs RVPH Comparison

Compare MCHX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • RVPH
  • Stock Information
  • Founded
  • MCHX 2003
  • RVPH 2006
  • Country
  • MCHX United States
  • RVPH United States
  • Employees
  • MCHX N/A
  • RVPH N/A
  • Industry
  • MCHX Business Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • MCHX Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • MCHX 84.3M
  • RVPH 88.0M
  • IPO Year
  • MCHX 2004
  • RVPH N/A
  • Fundamental
  • Price
  • MCHX $1.98
  • RVPH $1.84
  • Analyst Decision
  • MCHX
  • RVPH Strong Buy
  • Analyst Count
  • MCHX 0
  • RVPH 5
  • Target Price
  • MCHX N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • MCHX 28.2K
  • RVPH 1.7M
  • Earning Date
  • MCHX 03-13-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • MCHX N/A
  • RVPH N/A
  • EPS Growth
  • MCHX N/A
  • RVPH N/A
  • EPS
  • MCHX N/A
  • RVPH N/A
  • Revenue
  • MCHX $48,594,000.00
  • RVPH N/A
  • Revenue This Year
  • MCHX N/A
  • RVPH N/A
  • Revenue Next Year
  • MCHX $4.63
  • RVPH N/A
  • P/E Ratio
  • MCHX N/A
  • RVPH N/A
  • Revenue Growth
  • MCHX N/A
  • RVPH N/A
  • 52 Week Low
  • MCHX $1.11
  • RVPH $0.60
  • 52 Week High
  • MCHX $2.40
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 51.41
  • RVPH 48.62
  • Support Level
  • MCHX $1.88
  • RVPH $1.97
  • Resistance Level
  • MCHX $2.04
  • RVPH $2.14
  • Average True Range (ATR)
  • MCHX 0.09
  • RVPH 0.14
  • MACD
  • MCHX -0.00
  • RVPH -0.01
  • Stochastic Oscillator
  • MCHX 70.86
  • RVPH 40.43

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: